ReviewOncotarget2013

Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy.

Frank Louwen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.